checkAd
    Startseite > Aktien > ANI Pharmaceuticals > Nachrichten
    ANI Pharmaceuticals Aktie
    62,00
     
    EUR
    -2,36 %
    -1,50 EUR
    Letzter Kurs 07.06.24 Tradegate
    60,50
     
    EUR
    100 STK
    Geldkurs 21:15:21
    61,00
     
    EUR
    100 STK
    Briefkurs 21:15:21
    ISIN: US00182C1036 · WKN: A1W15D · SYM: BSFA · USA

    Neueste Nachrichten

    ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
    29.05.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals Announces the Launch of Kionex Suspension
    20.05.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
    10.05.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
    01.05.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8: 30 a.m. ET
    18.04.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
    09.04.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
    04.04.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium
    03.04.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
    27.03.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance
    29.02.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
    20.02.24 · globenewswire · ANI Pharmaceuticals
    ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8: 30 a.m. ET
    07.02.24 · globenewswire · ANI Pharmaceuticals